Caring
For You
CLINICAL TRIAL
A clinical trial with anAPPhylaxis has demonstrated an increase of satisfaction in the use of autoinjectors from 60% to 80% (p<0.0001) when anAPPhylaxis was used. 88% patients found anAPPhylaxis easy to use and 83% would use it frequently, and adherence to the treatment was significantly increased (p<0.001). Moreover, anxiety decreased “quite” or “a lot” in 95% of patients, and even though 7 anaphylactic events were registered during the study, all of them in the group without medical device.
WE LISTEN
If you had any incident, please report it using the form below.
We’d love to listen from you.